Actively Recruiting
Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
Led by Masaryk University · Updated on 2025-09-10
70
Participants Needed
2
Research Sites
69 weeks
Total Duration
On this page
Sponsors
M
Masaryk University
Lead Sponsor
B
Brno University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Approximately 30 minutes after needle EMG, patients who are taking direct oral anticoagulants (DOACs) will undergo an ultrasound examination to evaluate for the presence of possible intramuscular hematomas at the muscles where the EMG needle was inserted. These hematomas are considered a potential adverse effect of needle EMG. The aim of the study is to determine whether needle EMG can be considered a safe procedure in this group of patients, without posing a risk of intramuscular hematoma formation.
CONDITIONS
Official Title
Ultrasound Evaluation of Hematoma Risk After Needle EMG in Patient on DOAC Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Understand the nature of the study and provide signed and dated written informed consent before any study procedures
- Willing and able to comply with all study protocol procedures
- Confirmed daily and recent intake of direct oral anticoagulants at standard dosing
- Not taking any other antithrombotic drug therapy such as aspirin, clopidogrel, ticagrelol, low molecular weight heparin, or a second direct anticoagulant
You will not qualify if you...
- Any significant medical or psychiatric condition or history that could interfere with participation or increase risk according to the investigator
- Recent use of other antithrombotic drug therapies such as aspirin, clopidogrel, ticagrelol, low molecular weight heparin, or a second direct anticoagulant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital Brno
Brno, Czech Republic, Czechia, 62500
Actively Recruiting
2
University hospital Brno
Brno, Czech Republic, Czechia, 62500
Actively Recruiting
Research Team
A
Adam Betík, MD
CONTACT
E
Eva Vlckova, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here